Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Walgreens Boots ( NASDAQ: WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking to private equity confirms about debt financing for a potential takeover.

Find out why Walgreens Boots Alliance (WBA) stock fell over 7% in extended trading and why the drugstore chain is suspending ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...

Shares of Walgreens (NASDAQ: WBA) fell sharply by 9% following reports that a potential acquisition by private equity firm ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...

Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...